The presentation of the VenoValve trial results is directly related to enVVeno Medical's core business and future prospects. Positive trial results typically lead to increased investor confidence and can drive the stock price up, while negative results can lead to decreased confidence and a potential drop in stock price. Given the specificity of the event and its significance to the company's product pipeline, the impact on NVNO's stock is likely to be significant in the short term.